Puma Biotechnology (PBYI) Shareholder's Equity (2010 - 2026)

Puma Biotechnology (PBYI) Shareholder's Equity (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Puma Biotechnology 384.39 Mn 282.84 Mn 34.39 Mn 128.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 128.42 Mn
Dec 31, 2025 130.34 Mn
Sep 30, 2025 115.27 Mn
Jun 30, 2025 104.72 Mn
Mar 31, 2025 97.11 Mn
Dec 31, 2024 92.13 Mn
Sep 30, 2024 71.09 Mn
Jun 30, 2024 48.51 Mn
Mar 31, 2024 50.98 Mn
Dec 31, 2023 53.44 Mn
Sep 30, 2023 38.74 Mn
Jun 30, 2023 30.40 Mn
Mar 31, 2023 25.85 Mn
Dec 31, 2022 21.61 Mn
Sep 30, 2022 22.16 Mn
Jun 30, 2022 19.74 Mn
Mar 31, 2022 7.15 Mn
Dec 31, 2021 -2.45 Mn
Sep 30, 2021 -10.92 Mn
Jun 30, 2021 29.47 Mn